Litcius/Paper detail

Switch to long-acting cabotegravir and rilpivirine in virologically suppressed adults with HIV in Africa (CARES): week 48 results from a randomised, multicentre, open-label, non-inferiority trial

Cissy Kityo, Ivan Mambule, Joseph Musaazi, Simiso Sokhela, Henry Mugerwa, Gilbert Ategeka, Fiona V Cresswell, Abraham Siika, Josphat Kosgei, Reena Shah, Logashvari Naidoo, Kimton Opiyo, Caroline Otike, Karlien Möller, Arvind Kaimal, Charity Wambui, Veerle Van Eygen, Perry Mohammed, Fafa Addo Boateng, Nicholas I. Paton, Henry Mugerwa, William Tamale, Joshua Yiga, Susan Esther Asaasira, Nigel Kinyera, Christine Nambi, Dridah Luyirika Nakiboneka, Rose Kabatana, Winfred Kiyimba, Gilbert Ategeka, Ibrahim Yawe, Adolf Alinaitwe, Aidah Zawedde, George Wasswa, Allan Arinda, Angela Rweyora, Mary Goretti Kangah, Fiona Cresswell, Barbara Castelnuovo, Arvind Kaimal, Patience Ogwal, Neville Muhumuza, Max Okwero, Peruth Ayebare, Vivian Nakate, Jesca Asienzo, Hamza Mayanja, Eva Laker, Reena Shah, Felix Riunga, Peter Odhiambo Onyango, Josephine Wanja, Shaheen Sayed, Jaimini Gohil, Isaiah Mungathia, Alfred Mburu Githuka, Haron Kibwage, Abraham Mosigisi Siika, Charity Kanyoro Wambui, Viola Cherotich Kirui, Jairus Kipyego, Natalie Sang, Martha Mokeira Bisieri Mokaya, Consolata Chepkorir, Chris Sande Mboya, Ronald Tonui, Florence Njulu, Hilda Kaziga, Josphat Kosgei, Fredrick Sawe, Magdaline Adhiambo Omol, Faith Riziki, Ibrahim Daud, Leelgo Kimetto, Billy Omalla Okumu, Francis Lipuku, Simiso Sokhela, Francois Venter, Karlien Moller, Nompumelelo Nzuza, Gontse Ramela, Noxolo Tom, Tsitsi Nyamuzihwa, Philadelphia Macholo, Hlamulani Macebele, Godspower Akpomiemie, Logashvari Naidoo, Nitesha Jeenarain, Nivriti Hurbans, Mayuri Reddy, Gerald Thsepo Mphisa, Cissy Kityo, Nicholas Paton, Ivan Kiggundu Mambule, Kimton Opiyo, Joseph Musaazi, Caroline Otike, Ritah Kabanyoro, Francis Sekajja, Sandra Nantumbwe

2024The Lancet Infectious Diseases96 citationsDOIOpen Access PDF

Topics & Concepts

RilpivirineHuman immunodeficiency virus (HIV)MedicineOpen labelTenofovirRandomized controlled trialInternal medicineFamily medicineAntiretroviral therapyViral loadHIV/AIDS drug development and treatmentHIV-related health complications and treatmentsHIV Research and Treatment
Switch to long-acting cabotegravir and rilpivirine in virologically suppressed adults with HIV in Africa (CARES): week 48 results from a randomised, multicentre, open-label, non-inferiority trial | Litcius